KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to -$1.3 million.

  • Resmed's Change in Intangibles rose 2444.82% to -$1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.3 million, marking a year-over-year increase of 26476.19%. This contributed to the annual value of $10.8 million for FY2025, which is 3000.13% down from last year.
  • According to the latest figures from Q4 2025, Resmed's Change in Intangibles is -$1.3 million, which was up 2444.82% from $2.8 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Change in Intangibles ranged from a high of $10.8 million in Q3 2023 and a low of -$1.8 million during Q4 2024
  • For the 5-year period, Resmed's Change in Intangibles averaged around $3.4 million, with its median value being $3.1 million (2021).
  • In the last 5 years, Resmed's Change in Intangibles tumbled by 24663.9% in 2024 and then surged by 29541.19% in 2025.
  • Over the past 5 years, Resmed's Change in Intangibles (Quarter) stood at $9.3 million in 2021, then plummeted by 53.48% to $4.3 million in 2022, then crashed by 72.1% to $1.2 million in 2023, then tumbled by 246.64% to -$1.8 million in 2024, then increased by 24.45% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q4 2025, $2.8 million for Q3 2025, and $3.2 million during Q2 2025.